BioGaia AB (publ) (STO:BIOG.B)
Sweden
· Delayed Price · Currency is SEK 100.70
-1.20 (-1.18%)
Apr 24, 2025, 5:29 PM CET
BioGaia AB Revenue
In the year 2024, BioGaia AB had annual revenue of 1.42B SEK with 9.73% growth. BioGaia AB had revenue of 364.83M in the quarter ending December 31, 2024, with 22.52% growth.
Revenue
1.42B
Revenue Growth
+9.73%
P/S Ratio
7.16
Revenue / Employee
6.32M
Employees
225
Market Cap
10.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.42B | 126.21M | 9.73% |
| Dec 31, 2023 | 1.30B | 192.55M | 17.44% |
| Dec 31, 2022 | 1.10B | 318.85M | 40.61% |
| Dec 31, 2021 | 785.11M | 38.03M | 5.09% |
| Dec 31, 2020 | 747.08M | -21.27M | -2.77% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Vitrolife AB | 3.61B |
| Bonesupport Holding AB | 898.73M |
| Vimian Group AB | 4.29B |